GenMark's Q3 Revenues Nearly Double, Driven by Product Sales | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenMark Diagnostics today announced that revenues grew 92 percent as product revenues ballooned 84 percent.

Total revenues rose to $1.3 million for the three months ended Sept. 30 from $684,000 a year ago, paced by product revenues, which grew to $1.2 million from $656,000 a year. Product sales were comprised completely of reagent sales.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.